Beta-blockers and ACE inhibitors: New data, old myths

Gary S. Francis; William R Lewis; William Parmley; C. Wayne Weart

Beta-blockers and ACE inhibitors: New data, old myths

Gary S. Francis, William R Lewis, William Parmley, C. Wayne Weart

Cardiovascular Medicine

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Abstract

Clinical trials have demonstrated new, safe, efficacious ways to use these cardiovascular agents: Beta-blockers are now first-line treatment for heart failure, and the HOPE trial showed that ACE inhibitors reduce morbidity and mortality in patients at high risk of cardiac events.

Original language	English (US)
Pages (from-to)	62-84
Number of pages	23
Journal	Patient Care
Volume	34
Issue number	13
State	Published - 2000

ASJC Scopus subject areas

Leadership and Management

Fingerprint Dive into the research topics of 'Beta-blockers and ACE inhibitors: New data, old myths'. Together they form a unique fingerprint.

Cite this

@article{72271076404e4c82be1b4b91271565ce,

title = "Beta-blockers and ACE inhibitors: New data, old myths",

abstract = "Clinical trials have demonstrated new, safe, efficacious ways to use these cardiovascular agents: Beta-blockers are now first-line treatment for heart failure, and the HOPE trial showed that ACE inhibitors reduce morbidity and mortality in patients at high risk of cardiac events.",

author = "Francis, {Gary S.} and Lewis, {William R} and William Parmley and Weart, {C. Wayne}",

year = "2000",

language = "English (US)",

volume = "34",

pages = "62--84",

journal = "Patient Care",

issn = "0031-305X",

publisher = "Advanstar Communications",

number = "13",

}

TY - JOUR

T1 - Beta-blockers and ACE inhibitors

T2 - New data, old myths

AU - Francis, Gary S.

AU - Lewis, William R

AU - Parmley, William

AU - Weart, C. Wayne

PY - 2000

Y1 - 2000

N2 - Clinical trials have demonstrated new, safe, efficacious ways to use these cardiovascular agents: Beta-blockers are now first-line treatment for heart failure, and the HOPE trial showed that ACE inhibitors reduce morbidity and mortality in patients at high risk of cardiac events.

AB - Clinical trials have demonstrated new, safe, efficacious ways to use these cardiovascular agents: Beta-blockers are now first-line treatment for heart failure, and the HOPE trial showed that ACE inhibitors reduce morbidity and mortality in patients at high risk of cardiac events.

UR - http://www.scopus.com/inward/record.url?scp=0003010345&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0003010345&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0003010345

VL - 34

SP - 62

EP - 84

JO - Patient Care

JF - Patient Care

SN - 0031-305X

IS - 13

ER -

Beta-blockers and ACE inhibitors: New data, old myths

Abstract

ASJC Scopus subject areas

Other files and links

Cite this